These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 576150)

  • 21. [Plate thermography, a means of surveillance of the permeability of a peritoneo-venous shunt for ascites].
    Chevrel JP
    Nouv Presse Med; 1979 Mar; 8(11):870. PubMed ID: 450664
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatorenal syndrome. Reversal with LeVeen shunt.
    Grosberg SJ; Wapnick S; Leveen H; Reddy AN
    N Y State J Med; 1978 Mar; 78(4):637-9. PubMed ID: 273754
    [No Abstract]   [Full Text] [Related]  

  • 23. [Functional testing of a LeVeen peritoneal-venous shunt by scintigraphy].
    Botsch H; Gentz HD
    Rofo; 1979 Aug; 131(2):222-3. PubMed ID: 157965
    [No Abstract]   [Full Text] [Related]  

  • 24. Peritoneo-venous shunt for ascites.
    LeVeen HH; Wapnick S
    Surg Annu; 1978; 10():191-214. PubMed ID: 635737
    [No Abstract]   [Full Text] [Related]  

  • 25. Sounding boards. The LeVeen shunt for ascites and hepatorenal syndrome.
    Epstein M
    N Engl J Med; 1980 Mar; 302(11):628-30. PubMed ID: 6986021
    [No Abstract]   [Full Text] [Related]  

  • 26. Noninvasive determination of LeVeen shunt patency.
    Metzler M; Lichti E; Silver D
    Surgery; 1980 Jan; 87(1):106-8. PubMed ID: 7350714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peritoneal-internal jugular-superior caval shunt with the Le Veen apparatus for treatment of refractory ascites. Our experience].
    Magaldi R; Sarti S; Giannini E; De Santis S
    Minerva Med; 1980 Mar; 71(9):635-44. PubMed ID: 7360400
    [No Abstract]   [Full Text] [Related]  

  • 29. [The Doppler, a means of exploring a peritoneovenous shunt for ascites].
    Roncoroni L; Violi V; Beldrighi A; Salcuni P
    Nouv Presse Med; 1980 Mar; 9(13):965-6. PubMed ID: 7360633
    [No Abstract]   [Full Text] [Related]  

  • 30. [Surgical treatment of the ascitic patient using LeVeen peritoneojugular shunt. Personal case reports].
    Amerio A; Giudici Cipriani A; Cananzi C; Zanelli G; Zinicola N
    Minerva Chir; 1986 Feb; 41(3-4):125-33. PubMed ID: 3515230
    [No Abstract]   [Full Text] [Related]  

  • 31. [Consumption coagulopathy after peritoneojugular shunt (30 cases)].
    Robert A; Bloch P; Bionot C; Lévy VG; Huguet C
    Gastroenterol Clin Biol; 1980 May; 4(5):389. PubMed ID: 7399210
    [No Abstract]   [Full Text] [Related]  

  • 32. Patency of the peritoneovenous shunt.
    Rikkers LF; Fajman WA; Ansley JD; Tarcan YA
    Surg Gynecol Obstet; 1977 Nov; 145(5):745. PubMed ID: 910219
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatorenal syndrome: reversal by peritoneovenous shunt.
    Fullen WD
    Surgery; 1977 Sep; 82(3):337-41. PubMed ID: 888100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved renal function and inhibition of renin and aldosterone secretion following peritoneovenous (LeVeen) shunt.
    Berkowitz HD; Mullen JL; Miller LD; Rosato EF
    Surgery; 1978 Jul; 84(1):120-6. PubMed ID: 663820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Problems in abdominal surgery. I. Peritoneovenous shunting for intractable ascites.
    Barnett WO
    J Miss State Med Assoc; 1976 Jan; 17(1):5-7. PubMed ID: 1246076
    [No Abstract]   [Full Text] [Related]  

  • 36. [The peritoneal-jugular shunt in the patient with refractory ascites. Our experience].
    Sacco R; Strocchi F; Al Mahasneh AI; Tarantini M
    Ann Ital Chir; 1987; 59(1-6):377-81. PubMed ID: 3503624
    [No Abstract]   [Full Text] [Related]  

  • 37. Radionuclide assessment of peritoneo-venous shunt patency.
    Singh A; McAfee JG; Thomas FD; Grossman ZD
    Clin Nucl Med; 1979 Nov; 4(11):447-50. PubMed ID: 509842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
    Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
    Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scintiphotographic evaluation of LeVeen peritoneo-venous shunt patency using intraperitoneal Tc-99m-MAA.
    Farrer PA; Friede J; Wexler MJ
    Clin Nucl Med; 1979 Nov; 4(11):451-4. PubMed ID: 509843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.